Prof. Feng-Lai Yuan | Health | Best Researcher Award
Jiangnan University | China
Dr. Yuan Fenglai (M.D.) is a highly accomplished medical researcher with strong academic training, holding degrees in Medicine, Pharmacy, and a Doctorate from leading Chinese universities. He has served in prominent academic roles, including Associate Professor and Doctoral Supervisor at Nantong University, and currently serves as Professor, Doctoral Supervisor, and Director of the Science and Technology Department at the Affiliated Hospital of Jiangnan University. His research focuses on bone biology, osteoclast function, osteoporosis, wound healing, and fibrotic diseases, with impactful contributions to drug delivery systems, hydrogel-based tissue regeneration, and targeted therapies. Dr. Yuan has published high-impact papers in prestigious journals such as Ageing Research Reviews, Cell Death & Disease, Nano Research, and EBioMedicine, with several works as corresponding author. His studies on pH-sensitive bone-targeted estrogen delivery, podosome biology, hydrogels for wound regeneration, and antifibrotic mechanisms demonstrate both innovation and translational potential. Beyond the last five years, his earlier publications on long non-coding RNAs in osteoporosis, ion channel regulation in chondrocytes, and biomaterial scaffolds further highlight his consistent contributions to musculoskeletal research. With a record of interdisciplinary studies bridging molecular biology, biomaterials, and translational medicine, Dr. Yuan has established himself as a leading researcher with significant influence in regenerative medicine and therapeutic development.
Featured Publications
Lei-sheng Wang a b c , Yifei Fu a b , Shiwei Xu a b , Enhong Chen a , Shuo Zhang a , Dongjie Yang a , Youzhao He a , Yuanlong Gu a , Yong Mao a b , Fenglai Yuan a b , Hao Hu a b (2025). Targeting the PI3K-AKT pathway to alleviate 6PPDQ-induced cognitive impairment associated with metabolic syndrome.Ecotoxicology and Environmental Safety
Chen ZH; Du DY; Fu YF; Wu JJ; Guo DY; Li YY; Chen MN; Yuan ZD; Zhang KW; Zhang ZY et al (2023). Citric acid-modified pH-sensitive bone-targeted delivery of estrogen for the treatment of postmenopausal osteoporosis.Mater Today Bio.
Wu JJ; Sun ZL; Liu SY; Chen ZH; Yuan ZD; Zou ML; Teng YY; Li YY; Guo DY; Yuan FL (2022). The ASIC3-M-CSF-M2 macrophage-positive feedback loop modulates fibroblast-to-myofibroblast differentiation in skin fibrosis pathogenesis. Cell death & disease